2021
DOI: 10.1002/ctm2.564
|View full text |Cite
|
Sign up to set email alerts
|

Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
29
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(29 citation statements)
references
References 10 publications
0
29
0
Order By: Relevance
“…Interestingly, recent studies demonstrate that baicalein, a bioactive flavonoid, directly binds to toll-like receptor 4 (TLR4), hence reducing VEGF expression, which leads to the inhibition of tumor growth and angiogenesis and reduces the cancer’s metastatic potential [ 56 , 57 ].…”
Section: Possible Utilities Of Vegf Family Members In Colorectal Cancermentioning
confidence: 99%
“…Interestingly, recent studies demonstrate that baicalein, a bioactive flavonoid, directly binds to toll-like receptor 4 (TLR4), hence reducing VEGF expression, which leads to the inhibition of tumor growth and angiogenesis and reduces the cancer’s metastatic potential [ 56 , 57 ].…”
Section: Possible Utilities Of Vegf Family Members In Colorectal Cancermentioning
confidence: 99%
“…Then, a series of downstream signals are activated and finally upregulate the expression of pro-inflammatory cytokines ( Kumar et al, 2011 ; Moghimpour Bijani et al, 2012 ). It was reported that baicalein, a main component in SR, could directly bind to TLR4 to interrupt the formation of the complex (LPS-MD2-TLR4) ( Chen et al, 2021 ). Luteolin, 3′,4′,5,7-tetrahydroxyflavone, was found to significantly improve the survival rate of endotoxemia mice by combining in an interface of LPS and MD-2 to prevent the formation of the complex ( Yan et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…Toll-like receptor 4 (TLR4) could induce the PI3K/AKT signaling and play a central role in the progression of CRC [ 43 ]. Moreover, baicalein directly bound to TLR4 to inhibit TLR4/HIF-1α/VEGF signaling pathway and angiogenesis in CRC [ 44 ]. Ginkgetin and resveratrol could inhibit VEGF-mediated angiogenesis during tumorigenesis ( Figure 1 ).…”
Section: Vegf Signaling Pathway In Crcmentioning
confidence: 99%